重庆特色诊疗方案：

Chongqing characteristic diagnosis and treatment plan:

慢性乙型肝炎抗病毒治疗与临床功能性治愈（New Switch研究）、人工肝支持治疗、疑难感染与重症传染病救治、中医/中西医结合辨证施治、中药汤剂与院内制剂、肝硬化并发症中医药干预

Antiviral therapy and clinical functional cure of chronic hepatitis B (New Switch study); artificial liver support therapy; management of complex infections and severe infectious diseases; TCM and integrated Chinese–Western medicine treatment based on syndrome differentiation; herbal decoctions and in-hospital preparations; TCM intervention for cirrhosis complications

国家首批重点学科、国家临床重点专科；建有全球最大慢性乙型肝炎研究队列；感染性疾病分子生物学教育部重点实验室；国家中医肝胆病优势专科、国家中医药管理局“十二五”肝病重点专科；西南区域规模最大、综合水平最精准的中医肝病诊疗中心

One of the first national key disciplines and national clinical key specialties; maintains the world's largest chronic hepatitis B research cohort; MOE Key Laboratory of Molecular Biology of Infectious Diseases; National TCM Advantage Specialty in Hepatobiliary Diseases; NADS “Twelfth Five-Year” Key Specialty in Liver Diseases; the largest and most comprehensive TCM liver disease center in Southwest China

中西医抗病毒治疗长期（以年计）；重症肝病人工肝支持住院1-2周

Long-term (measured in years) integrated Chinese–Western antiviral therapy; severe liver disease with artificial liver support: 1–2 weeks in hospital